We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genetic testing in focal segmental glomerulosclerosis: in whom and when?
- Authors
Tato, Ana María; Carrera, Noa; García-Murias, Maria; Shabaka, Amir; Ávila, Ana; Mora, María Teresa Mora; Rabasco, Cristina; Soto, Karina; Alvarez, Francisco Jose de la Prada; Fernández-Lorente, Loreto; Rodríguez-Moreno, Antolina; Huerta, Ana; Mon, Carmen; García-Carro, Clara; Cabrera, Fayna González; Navarro, Juan Antonio Martín; Romera, Ana; Gutiérrez, Eduardo; Villacorta, Javier; Lorenzo, Alberto de
- Abstract
Background Genetic causes are increasingly recognized in patients with focal segmental glomerulosclerosis (FSGS), but it remains unclear which patients should undergo genetic study. Our objective was to determine the frequency and distribution of genetic variants in steroid-resistant nephrotic syndrome FSGS (SRNS-FSGS) and in FSGS of undetermined cause (FSGS-UC). Methods We performed targeted exome sequencing of 84 genes associated with glomerulopathy in patients with adult-onset SRNS-FSGS or FSGS-UC after ruling out secondary causes. Results Seventy-six patients met the study criteria; 24 presented with SRNS-FSGS and 52 with FSGS-UC. We detected FSGS-related disease-causing variants in 27/76 patients (35.5%). There were no differences between genetic and non-genetic causes in age, proteinuria, glomerular filtration rate, serum albumin, body mass index, hypertension, diabetes or family history. Hematuria was more prevalent among patients with genetic causes. We found 19 pathogenic variants in COL4A3–5 genes in 16 (29.3%) patients. NPHS2 mutations were identified in 6 (16.2%) patients. The remaining cases had variants affecting INF2, OCRL, ACTN4 genes or APOL1 high-risk alleles. FSGS-related genetic variants were more common in SRNS-FSGS than in FSGS-UC (41.7% vs 32.7%). Four SRNS-FSGS patients presented with NPHS2 disease-causing variants. COL4A variants were the most prevalent finding in FSGS-UC patients, with 12 patients carrying disease-causing variants in these genes. Conclusions FSGS-related variants were detected in a substantial number of patients with SRNS-FSGS or FSGS-UC, regardless of age of onset of disease or the patient's family history. In our experience, genetic testing should be performed in routine clinical practice for the diagnosis of this group of patients.
- Subjects
FOCAL segmental glomerulosclerosis; GENETIC testing; GLOMERULAR filtration rate; BODY mass index; SERUM albumin; GENETIC variation; PEDIATRIC nephrology
- Publication
Clinical Kidney Journal, 2023, Vol 16, Issue 11, p2011
- ISSN
2048-8505
- Publication type
Article
- DOI
10.1093/ckj/sfad193